NEW YORK (GenomeWeb News) — Rand Capital and SCP Buffalo Incubator Innovate NY Fund said yesterday that they have invested $1 million in privately held molecular diagnostics firm Empire Genomics.

Based in Buffalo, NY, Empire Genomics offers testing products and services for cancer disease management that enable physicians to improve their diagnostic capabilities and tailor specific therapeutic treatments using patient DNA.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: spatiotemporal study of lncRNA expression, role of extrachromosomal, circular DNAs in yeast, and more.

A European team has launched a four-year study to develop a test to gauge cervical, ovarian, uterine, or aggressive breast cancer risk in women.

As interest in personalized medicine grows, government contractors are entering the field, the Washington Post reports.

The New York Times editorial board weighs in on scientific research misconduct.